• Establishing pharmacologically relevant exposure levels and engagement are two key steps in target validation. • There is a need for better biomarkers to objectively measure biological states and ...

Genomic data is rapidly reshaping drug development, but not all data delivers the same value. For biopharma teams, the ability to accurately identify patients, understand disease burden, and make ...

Functional genomics is central to modern drug discovery, yet high attrition rates persist. In this article, Dr Salman ...

Hit identification and hit validation represent distinct but connected stages of early drug discovery. This article examines ...

This eBook is designed to deliver both strategic insight and practical guidance. It opens with a White Paper informed by ...

Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...

In 2026, AI moved from experimental promise to clinical reality, delivering breakthroughs in drug discovery, emergency diagnostics, and workflow automation. From Insilico Medicine’s rapid development ...

Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it ...

Insilico Medicine announced LabClaw, an intelligent laboratory operating system designed to enable autonomous coordination ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing innovative combination therapies for high-impact indications, today announced it has been named the winner ...